论文部分内容阅读
近日,经国务院同意,国家卫生计生委、国家发改委、工信部、人社部、国家食品药品监督管理总局、国家中医药管理局联合印发《关于保障儿童用药的若干意见》,从鼓励研发创制、加快申报审评、确保生产供应、强化质量监管、推动合理用药、完善体系建设、提升综合能力等环节,对保障儿童用药提出了具体要求。这是近十几年来我国关于儿童用药的第一个综合性指导文件。
Recently, with the approval of the State Council, the State Health and Family Planning Commission, the National Development and Reform Commission, the Ministry of Industry and Information Technology, the Ministry of Human Resources and Social Security, the State Food and Drug Administration and the State Administration of Traditional Chinese Medicine jointly issued the “Opinions on the Protection of Children’s Medication,” which encourage R & D to create and accelerate Declare the review and appraisal, ensure production and supply, strengthen quality control, promote the rational use of medicines, improve the system construction, and enhance the overall ability and other sectors, and put forward specific requirements for the protection of children’s medication. This is the first comprehensive guidance document for children’s medication in China in the past decade or so.